Direktorat Registrasi ObatValid

XIGDUO XR

Claim this product
BPOM Number
DKI2527900214A1
Approved
13 April 2026
Expiry
18 June 2028
Form
TABLET SALUT SELAPUT PELEPASAN LAMBAT

About This Registration

XIGDUO XR is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2527900214A1. Its current registration status is Valid, with the licence valid until 18 June 2028. The product is registered to ASTRAZENECA INDONESIA - INDONESIA. BPOM first approved this registration in March 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 4 BLISTER @ 7 TABLET SALUT SELAPUT PELEPASAN LAMBAT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (3)

DAPAGLIFLOZIN PROPANEDIOL<BR>METFORMIN HYDROCHLORIDE

Market Intelligence

Owner Portfolio
ASTRAZENECA INDONESIA - INDONESIA holds 103 BPOM registrations
Manufacturer Scale
ASTRAZENECA INDONESIA - INDONESIA produces 103 registered products
Registration Age
Registered for 3 months

FDA Cross-Reference

via openFDA
Generic Name
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from ASTRAZENECA INDONESIA - INDONESIA

BETALOC ZOK

-DKI2151304214B1
Valid
Approved: Jul 1, 2026TABLET PELEPASAN LAMBAT
View product →

AIRSUPRA

-DKI2604900539A1
Valid
Approved: Jun 2, 2026AEROSOL INHALASI (PRESSURED METERED DOSE INHALER/PMDI)
View product →

QTERN

-LKE26089007
Valid
Approved: May 24, 2026TABLET SALUT SELAPUT
View product →

XIGDUO XR

-DKI2527900214A1
Valid
Approved: Mar 31, 2026TABLET SALUT SELAPUT PELEPASAN LAMBAT
View product →

FASENRA

-DKI2251304343A1
Valid
Approved: Dec 30, 2025LARUTAN INJEKSI
View product →

Products in the same class

EPIVEN

-DKL0533514701A1
Valid
Approved: Sep 12, 2025KAPSUL
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

ZIFAGRA 100

-DKL2009226209A1
Valid
Approved: May 23, 2025KAPLET SALUT SELAPUT
IFARS PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

IRVELL

-DKL0133502517B1
Valid
Approved: May 23, 2025TABLET SALUT SELAPUT
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

TENOFOVIR DISOPROXIL FUMARATE

-GKL2544600717A1
Valid
Approved: Apr 14, 2025TABLET SALUT SELAPUT
SAMPHARINDO RETROVIRAL INDONESIA - INDONESIA
View product →

NEUROTROPIC

-DKL9610701243A1
Valid
Approved: Mar 12, 2025INJEKSI
GLOBAL MULTI PHARMALAB
View product →
1